TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Total Change Scores on Resilience Scale for Adults (RSA)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes in food preferences
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: efficiency of ridge widening technique
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduction in the number of wet nights
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Heart failure worsening
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean Change in Plasma cGMP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cutaneous and infectious complications
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Infusion Withdrawals, Interruptions, and Infusion Rate Reductions due to TAK-881-related TEAEs
Endpoint domain: Adverse events/effects
Primary endpoint: Composite incidence of procedure-related and device-related serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Treatment success defined as successful isolation of pulmonary veins and absence of recurrence or interventions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Ultrasound detected enthesitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Fidelity to Parent Activation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number and severity of criminal charges
Endpoint domain: Adverse events/effects
Primary endpoint: peak systolic velocity through the deployed stent
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Overall tumour Response Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Engagement in Treatment
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Attainment of recruitment goal
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Participants' satisfaction of protocol procedures (acceptability)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Adherence to protocol procedures
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Retention Rate in each group
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Behavioral measure
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of Participants Experiencing Treatment-Related Toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Platelet Engraftment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Maximum inspiratory pressure by spirometry
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Maximum expiratory pressure by spirometry
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Borg Rating of Perceived Exertion Scale
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: 2 minute stationary walk test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nature, incidence, and severity of adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Pain from the Burn Wound
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Identification of middle ear structures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Pediatric Quality of Life (PedsQL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in Obstructive Sleep Apnea -18 (OSA-18)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: IBS-SSS at 8 Weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of individuals with heavy metal contaminants in home water samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of individuals with heavy metal and metalloid contaminations in blood biospecimens
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of individuals with heavy metal and metalloid contaminations in urine biospecimens
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of individuals with insufficient blood serum micronutrient levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportion of individuals with health disorders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Enhancement of SubtleGAD in MR images
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in depression score over time
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in anxiety score over time
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in well-being score over time
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Organ failure
Endpoint domain: Mortality/survival
Primary endpoint: Vertigo symptom Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Pain Intensity changes from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of symptomatic RT-PCR confirmed SARS-CoV-2 infection
Endpoint domain: Mortality/survival
Primary endpoint: Marital adjustment score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Prenatal attachment score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Father attachment score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Apgar score <7
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Apgar score <10
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Seeking care due to decreased fetal movements
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in average daily OFF time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Concentration-time Curve From Time Zero to the Last Quantifiable Concentration (AUC0-t)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cell culture viability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FibroScan-aspartate aminotransferase (FAST) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of ocular adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency of treatment-emergent non-serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency of adverse device effects
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency of serious adverse device effects
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency of rectal bleeding of grade 1 or higher
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants with chorioamnionitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: LV thrombus resolution
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of Rotator cuff re-tears
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Delivery admission hemoglobin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Third trimester hemoglobin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Laboratory abnormality profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of Anti RBD antibody
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Interferon gamma level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Distance between anatomical points on the face
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Periorbital volume measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: All Case Mortality by Day 28
Endpoint domain: Mortality/survival
Primary endpoint: Recommended Phase 2 Dose (RP2D) of GEN2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in pelvic incidence (PI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in symphysis to sacrococcygeal junction distance (PSCD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in pelvic tilt (PT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in sacral slope (SS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in lumbar lordosis (LL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bowel Preparation Quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Time-weighted Area Under the Curve (AUC) of NRS pain scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cervical mobility
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Functional evaluation of the temporomandibular joint
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Child influenza vaccination status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of days spent outside the hospital and ED
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Cmax of Aramchol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUClast of Aramchol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUCinf of Aramchol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in postprandial glucose response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Score Upper Quarter Y Balance Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Shoulder rotators isometric strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline Quick Inventory of Depressive Symptomatology (QIDS-C16)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Exercise Flat Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline Pelvic Floor Muscle Activity (PFMA) at 8 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline Visual Analogue Scale (VAS) at 8 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline McGill Pain Scale- Short Form at 8 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: adherence to the rehabilitation program
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Semen parameters percentage improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Daily compliance
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Moral dilemma judgments
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: incidence of Postoperative myocardial injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: NDI score change
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Total dose of morphine in the first 24 h postoperatively
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Early airway obstruction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Tobacco Smoking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sleeping Pattern and Quality
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Perceived Physical Fitness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Physical Fitness- Body Composition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical Fitness- Flexibility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical Fitness- Muscular strength and endurance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hand Function - Box and Block Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hand Function - Nine Hole Peg Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: collected tumor samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: collected blood samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Number of participants with incident stroke, transient ischaemic attack, atrial fibrillation, myocardial infarction and heart failure
Endpoint domain: Mortality/survival
Primary endpoint: Number of participants with incident cognitive impairment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of participants with incident dementia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in QIDS-SR depression scale score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Antibody generation capability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in gastrointestinal symptom distress Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Incidence of Deep Vein Thrombosis (DVT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Change in adipose layer thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in muscle layer thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Observational Gait Analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: nursing students' personality traits
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: nursing students' competence in workplace violence management
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bone healing (ossification) of the fracture, osteotomy and arthrodesis lines
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of revision surgeries
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Time to resolution of signs and symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum venom concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: procedure related pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: emotional appearance
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Montreal Cognitive Scale (MoCA) scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in gait efficacy assessed by walking speed (m/s)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Desynchronization Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decreasing of sensoric feeling of tinnitus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changing of life quality due to tinnitus
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Caffeine daily intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: vascular refilling rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Amount of cerebral blood flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change of parental anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change of parental uncertainty
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Xanthine Oxidoreductase (XOR) Activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection of ISUP ≥2 cancers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Waist(cm)/Hip(cm) Ratio (%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient reported pain satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Proportion of screening-eligible visits at which patients were screened for mental health
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Proportion of visits at which patients endorsed suicidal ideation at which a suicide risk assessment was completed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients who were appropriately initiated on mental health treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of follow-up visits at which clinical decisions followed mental health treatment guidelines
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Proportion of Counseling sessions meeting Fidelity Threshold
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Proportion of women who accept the invitation to participate in the research study
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Adverse events that may occur during the trial
Endpoint domain: Adverse events/effects
Primary endpoint: Acceptability and feasibility of the selected procedures
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Satisfaction with Outcome
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: AUC0-t of 116-N1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Plasma Concentration (Cmax) of 116-N1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Heart Failure Symptom Status
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Frequency of Adverse Events in Part 1
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants with Adverse Events in Part 1
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency of Adverse Events in Part 2
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants with Adverse Events in Part 2
Endpoint domain: Adverse events/effects
Primary endpoint: Cognitive response
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change from baseline central macular thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of persistent severe AKI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Onset of Early cGvHD
Endpoint domain: Adverse events/effects
Primary endpoint: Onset of cGvHD or L-aGvHD
Endpoint domain: Adverse events/effects
Primary endpoint: No cGvHD or L-aGvHD
Endpoint domain: Adverse events/effects
Primary endpoint: Mean 24 hour glucose difference
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: thoracic volume variations change from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cardiac index change from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: systemic vascular resistance change from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: stroke volume variation change from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Improved Functional Capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improved Peripheral muscle strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Return to work after acute coronary syndrome
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Number of patients affected by Surgical Site Occurrence
Endpoint domain: Adverse events/effects
Primary endpoint: Presence of NAFLD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: COviD-19 vaccine specific antibody levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Maximum observed serum concentration (Cmax) for famitinib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the concentration-time curve from time zero to time t (AUC0-t) for famitinib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the concentration-time curve extrapolated to infinity (AUC0-∞) for famitinib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: changes of well being level
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing